Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

TRANSGENDER MEDICINE

Advancing knowledge of transgender medical intervention effects

In a recently published study, surveys of transgender individuals on hormone therapy provide insight into the self-reported effects of medication where previous thinking was only speculative. Still, controlled studies are required to avoid overinterpreting the clinical significance of specific findings in the context of what might be expected in the general population.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Weinand, J. D. & Safer, J. D. Hormone therapy in transgender adults is safe with provider supervision; a review of hormone therapy sequelae for transgender individuals. J. Clin. Transl Endocrinol. 2, 55–60 (2015).

    PubMed  PubMed Central  Google Scholar 

  2. Safer, J. D. & Tangpricha, V. Care of the transgender patient. Ann. Intern. Med. 171, ITC1–ITC16 (2019).

    Article  Google Scholar 

  3. Wierckx, K. et al. Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European Network for the Investigation of Gender Incongruence. J. Sex Med. 11, 1999–2011 (2014).

    Article  CAS  Google Scholar 

  4. Bisson, J. R., Chan, K. J. & Safer, J. D. Prolactin levels do not rise among transgender women treated with estradiol and spironolactone. Endocr. Pract. 24, 646–651 (2018).

    Article  Google Scholar 

  5. Chan, K. J. et al. Estrogen levels do not rise with testosterone treatment for transgender men. Endocr. Pract. 24, 329–333 (2018).

    Article  Google Scholar 

  6. Hembree, W. C. et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 102, 3869–3903 (2017).

    Article  Google Scholar 

  7. Coleman, E. et al. Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int. J. Transgend. 13, 165–232 (2012).

    Article  Google Scholar 

  8. van Dijk, D. et al. Explorative prospective evaluation of short-term subjective effects of hormonal treatment in trans people – results from the European Network for the Investigation of Gender Incongruence. J. Sex. Med. 16, 1297–1309 (2019).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joshua D. Safer.

Ethics declarations

Competing interests

J.D.S. served on an advisory panel for Endo Pharmaceuticals in June 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safer, J.D. Advancing knowledge of transgender medical intervention effects. Nat Rev Urol 16, 642–643 (2019). https://doi.org/10.1038/s41585-019-0222-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41585-019-0222-2

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing